Feed/Companies/Switchpoint Bio

Switchpoint Bio

As of 11 Nov 2026, Switchpoint Bio has raised $5.3M across 1 verified round on record; latest: $5.3 million pre-seed round, announced 10 Nov 2026.

They provide a blood-based epigenomic platform for drug developers to understand how disease and treatment affect human biology.

switchpointbio.comLinkedInHelsinki and Cambridge, MassachusettsBiotech

LATEST ROUND

Pre-seed

$5.3M · 2026-11-10

RAISED ON RECORD · USD

$5.3M

across 1 verified round

INVESTORS

no lead named

SOURCES

from 5 publishers

Company

Every round on record, with the sources behind each and the investors on them.

[ 1 ]

Pre-seed

$5.3M · 2026-11-10

lead not stated

Round	Amount	Announced	Lead	Buzz
Pre-seed	$5.3M	2026-11-10	not stated	5 outlets. #56 in Trending
5 sources · checked 1 time, last 5h ago [ VERIFIED · CORRECTED ] read against 1 of 5 sources The source names Treehouse Delmar Investments as making a $5 million investment, but does not call it a lead investor. Helsinki and Cambridge are locations mentioned in the article, not stated headquarters.; not on the page it cites, so not applied: date

Does: They provide a blood-based epigenomic platform for drug developers to understand how disease and treatment affect human biology.

[ 5 ]